Buy Abbott

Logo for stock ABT (Abbott)

Amount

£
GBP

Latest price

$132.61
(£1.00 = $1.327)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$230.702B

P/E ratio

17.16

EPS

$7.725

Beta

0.74

Dividend rate

$2.28

Dividend yield

1.72%

About

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.

CEO

Mr. Robert B. Ford

Employees

114,000

Sector

Health

Company HQ

ABBOTT PARK, United States of America

Website

News

Logo for news article #0 (MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know)

MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know

Most of the MedTech players have adjusted their 2025 forecasts in response to rising tariff pressure.

Zacks Investment Research

May 05, 2025

Logo for news article #1 (Abbott Labs CEO on federal health care spending, investing in healthy people and weight loss drugs)

Abbott Labs CEO on federal health care spending, investing in healthy people and weight loss drugs

Robert Ford, Abbott Labs CEO, joins 'Power Lunch' to discuss government spending on health care and technological investments.

CNBC Television

May 05, 2025

Logo for news article #2 (2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?)

2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?

Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those that have done so for a long time -- generally have stable and steadily growing businesses that can perform relatively well even amid downturns.

The Motley Fool

May 03, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2025 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies Ltd is an Introducer Appointed Representative of Quint Group Limited, which is authorised and regulated by the Financial Conduct Authority (FRN 669450). Emma Technologies Ltd is not a lender. Emma Technologies Ltd introduces customers to Monevo Limited who is a licensed credit broker.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.